Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05985538 · ClinicalTrials.gov registry record · NA
Impact of E-Cigarette Prevention Messages on Adolescents
A NA study of Vaping Behavior, sponsored by UNC Lineberger Comprehensive Cancer Center.
- Completed
- Registry status
- NA
- Development phase
- 480
- Enrollment target
- 1
- Study location
NCT05985538: Completed NA study of Vaping Behavior, sponsored by UNC Lineberger Comprehensive Cancer Center.
NCT05985538 is a NA study of Vaping Behavior that has completed, run by UNC Lineberger Comprehensive Cancer Center. The registered enrollment target is 480 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (66% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05985538, a NA study of Vaping Behavior, has completed, sponsored by UNC Lineberger Comprehensive Cancer Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 480 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this trial is to determine whether a vaping prevention text message program reduces susceptibility to vaping among adolescents and young adults. This study addresses this issue by exposing participants to a vaping prevention text message program over a 28-day period in a randomized controlled trial with a matched attention control condition. A follow-up assessment is also made 4 weeks after the text messaging ends.
Primary Outcome
The mean susceptibility to vaping score will be assessed using the questionnaire. Response options are on a 1 to 4 scale. Overall scale scores are determined by summing scores of the 3 items and dividing them by 3 (range 1-4), with higher scores representing a greater susceptibility to vaping (a worse outcome).
Conditions Studied
Interventions
- BEHAVIORAL Vaping prevention text messages
- BEHAVIORAL Wellness behaviors text messages
Study Locations (1)
North Carolina
- University of North Carolina, Chapel Hill - Chapel Hill
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 480 participants |
| Start Date | 2024-02-05 |
| Est. Completion | 2024-08-12 |
| Phase | NA |
What the finished NCT05985538 record still lists
NCT05985538 is an interventional study that assigns participants to a tested intervention. The registered 480 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (66% lower).
The record links to 1 condition, with Vaping Behavior appearing as the primary indexed condition, and to 2 interventions - of which Vaping prevention text messages is the first listed.
NCT05985538 reports a single indexed study location in North Carolina.
Frequently Asked Questions
What is clinical trial NCT05985538 about?
NCT05985538 is a clinical study titled "Impact of E-Cigarette Prevention Messages on Adolescents". The purpose of this trial is to determine whether a vaping prevention text message program reduces susceptibility to vaping among adolescents and young adults. This study addresses this issue by exposing participants to a vaping prevention text message program over a 28-day period in a randomized co...
What is the current status of trial NCT05985538?
This trial is currently completed. It is a NA study. The enrollment target is 480 participants. The study started on 2024-02-05. Estimated completion is 2024-08-12.
What conditions does trial NCT05985538 study?
This clinical trial studies the following conditions: Vaping Behavior.
What interventions are being tested in trial NCT05985538?
The interventions under investigation include: Vaping prevention text messages (BEHAVIORAL), Wellness behaviors text messages (BEHAVIORAL).
Who is sponsoring clinical trial NCT05985538?
This trial is sponsored by UNC Lineberger Comprehensive Cancer Center, which has 366 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05985538 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Vaping Behavior
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05985538's enrollment target sits among peer trials
480 216th of 2000 higher than 1,783 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01954992 · 480 participants · Phase 3
Glufosfamide Versus 5-FU in Second Line Metastatic Pancreatic Cancer
- NCT03023696 · 480 participants · NA
Can Prophylactic Foraminotomy Prevent C5 Palsy
- NCT04948060 · 480 participants · NA
Tribally Engaged Approaches to Lung Screening (TEALS)
- NCT05053230 · 480 participants · NA
A Study Evaluating the Integrative Medicine at Home (IM@HOME) Program in People With Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI